Seranovo
Leiden
About Seranovo
SeraNovo is a pharma firm that offers a unique technological platform to increase the bioavailability of water-insoluble medicines. Their proprietary technologies include enhancing bioavailability and reducing development time for the clinic. Their technology harnesses the unique benefits of deep eutectic solvents to create powerful, tailor-made solubility-enhancing formulations that are well tolerated and simple to produce.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $340.1K
- Funding stage: Seed
- Last round: Seed (Mar 2019)
- Website: seranovo.com
- Phone: [email protected]
Industries & Categories
Biopharma, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/seranovo-82563 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.